Safety and Efficacy of Inhaled Nebulized Interferon Beta-1a for Treatment of SARS-CoV-2 Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Inhaled Nebulised Interferon Beta-1a (SNG001) for Treatment of SARS-CoV-2 Infection: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
Lancet Respir Med 2020 Nov 12;[EPub Ahead of Print], PD Monk, RJ Marsden, VJ Tear, J Brookes, TN Batten, M Mankowski, FJ Gabbay, DE Davies, ST Holgate, LP Ho, T Clark, R Djukanovic, TMA WilkinsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.